Modeling human neurodevelopmental disorders in the Xenopus tadpole: from mechanisms to therapeutic targets

被引:72
|
作者
Pratt, Kara G. [1 ]
Khakhalin, Arseny S. [2 ]
机构
[1] Univ Wyoming, Laramie, WY 82071 USA
[2] Brown Univ, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
AUTISM SPECTRUM DISORDERS; SINGLE-CELL ELECTROPORATION; DEVELOPING VISUAL-SYSTEM; RETINAL GANGLION-CELLS; AXON BRANCH DYNAMICS; ACTIVITY IN-VIVO; OPTIC TECTUM; FRAGILE-X; LAEVIS TADPOLES; RETT-SYNDROME;
D O I
10.1242/dmm.012138
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Xenopus tadpole model offers many advantages for studying the molecular, cellular and network mechanisms underlying neurodevelopmental disorders. Essentially every stage of normal neural circuit development, from axon outgrowth and guidance to activity-dependent homeostasis and refinement, has been studied in the frog tadpole, making it an ideal model to determine what happens when any of these stages are compromised. Recently, the tadpole model has been used to explore the mechanisms of epilepsy and autism, and there is mounting evidence to suggest that diseases of the nervous system involve deficits in the most fundamental aspects of nervous system function and development. In this Review, we provide an update on how tadpole models are being used to study three distinct types of neurodevelopmental disorders: diseases caused by exposure to environmental toxicants, epilepsy and seizure disorders, and autism.
引用
收藏
页码:1057 / 1065
页数:9
相关论文
共 50 条
  • [31] Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes
    Mullin, A. P.
    Gokhale, A.
    Moreno-De-Luca, A.
    Sanyal, S.
    Waddington, J. L.
    Faundez, V.
    TRANSLATIONAL PSYCHIATRY, 2013, 3 : e329 - e329
  • [33] Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside
    Illario, Maddalena
    Di Somma, Carolina
    Iaccarino, Guido
    Campiglia, Pietro
    Sankar, Uma
    Montuori, Nunzia
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [34] Network modeling to identify new mechanisms and therapeutic targets for Parkinson's disease
    MacArthur, Linda
    Ressom, Habtom
    Shah, Salim
    Federoff, Howard J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (06) : 685 - 693
  • [35] Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models
    Megagiannis, Platon
    Suresh, Rahul
    Rouleau, Guy A.
    Zhou, Yang
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 191
  • [36] Special issue on "molecular mechanisms and new therapeutic targets in human carcinogenesis"
    Feo, Francesco
    Poli, Giuseppe
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (02) : 133 - 134
  • [37] Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets
    Zhou, Yang
    Monnier, Philippe Patrick
    Feng, Jin-Zhou
    Guo, Shou-Gang
    Wang, Cong-Cong
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [38] FROM BASIC MECHANISMS TO THERAPEUTIC TARGETS IN HUNTINGTON'S DISEASE
    Thompson, L. M.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 13 - 13
  • [39] Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
    Slyepchenko, Anastasiya
    Carvalho, Andre F.
    Cha, Danielle S.
    Kasper, Siegfried
    McIntyre, Roger S.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (10) : 1770 - 1786
  • [40] Gut microbiota biofilms: From regulatory mechanisms to therapeutic targets
    Buret, Andre G.
    Allain, Thibault
    JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (03):